Histopathologic features of hepatocellular carcinoma
Elizabeth M. Brunt – 23 January 2013 – Watch a video presentation of this article
Systemic targeted therapy beyond sorafenib
Roniel Cabrera – 23 January 2013 – Watch a video presentation of this article
Laparoscopic liver resection for hepatocellular carcinoma: Indications and role
Adam C. Yopp, Amit G. Singal – 23 January 2013 – Watch a video presentation of this article
Systemic targeted therapy beyond sorafenib
Roniel Cabrera – 23 January 2013 – Watch a video presentation of this article
Systemic targeted therapy beyond sorafenib
Roniel Cabrera – 23 January 2013 – Watch a video presentation of this article
Current issues and future trends in surveillance for hepatocellular carcinoma
Robert S. Rahimi, Adam C. Yopp, Amit G. Singal – 23 January 2013 – Watch a video presentation of this article
Current issues and future trends in surveillance for hepatocellular carcinoma
Robert S. Rahimi, Adam C. Yopp, Amit G. Singal – 23 January 2013 – Watch a video presentation of this article
Radiological diagnosis of hepatocellular carcinoma
Mark W. Russo, Christoph Wald – 23 January 2013 – Watch a video presentation of this article
What primary care providers need to know about hepatocellular carcinoma
Parul Dureja Agarwal – 23 January 2013 – Watch a video presentation of this article
Hepatocyte caspase‐8 is an essential modulator of steatohepatitis in rodents
Maximilian Hatting, Gang Zhao, Fabienne Schumacher, Gernot Sellge, Malika Al Masaoudi, Nikolaus Gaβler, Mark Boekschoten, Michael Müller, Christian Liedtke, Francisco Javier Cubero, Christian Trautwein – 21 January 2013 – In human and murine models of nonalcoholic steatohepatitis (NASH), increased hepatocyte apoptosis is a critical mechanism contributing to inflammation and fibrogenesis. Caspase 8 (Casp8) is essential for death‐receptor‐mediated apoptosis activity and therefore its modulation might be critical for the pathogenesis of NASH.